Tradestie Institutional Equity Comparison Engine
BMM vs HCM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HCM Overall Edge
HCM Captures Institutional Edge (4โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HUTCHMED (China) Limited American Depositary Shares (HCM) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BMM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HCM at N/M Forward P/E and -6.3% operating margin (+0.2% YoY). In options structure, BMM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HCM sits in UNCLASSIFIED (73rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
HCM
BMM N/M vs HCM N/M Fwd P/E
Growth & Margin Winner
HCM
Op Margin N/A vs -6.3% ยท YoY N/A vs +0.2%
Momentum & Technical Winner
HCM
1Y -44.7% vs -9.8% ยท 52W Pos 0% vs 53%
Options & Structure Winner
HCM
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (73rd %ile IV)
BMM
US Equity
BMM
Institutional Equity
$2.50
-8.42% 1D
Market Cap
N/A
1M Return
-36.55%
1Y Return
-44.69%
Forward P/E
N/M
Unified AI Score
38.2 / 100
SELL
Tech 25.0
Fund 39.0
Flow 50.0
Mom 34.0
HCM
NASDAQ
HUTCHMED (China) Limited American Depositary Shares
Pharmaceutical Preparations
$13.22
-1.71% 1D
Market Cap
$2.3B
1M Return
-7.42%
1Y Return
-9.82%
Forward P/E
N/M
Unified AI Score
38.1 / 100
SELL
Tech 31.0
Fund 44.0
Flow 50.0
Mom 56.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BMM -44.69%
HCM -9.82%
Spread: +29.6 pp (HCM Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BMM TTM Op. Margin: N/A
HCM TTM Op. Margin: -6.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BMM vs HCM. Trailing 12-month operating profitability (BMM N/A vs HCM -6.3%) and valuation multiples (BMM N/M vs HCM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BMM | HCM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $2.3B | Larger Scale | HCM |
| Trailing P/E Ratio Valuation | N/M | 134.0x | Lower Multiple | HCM |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.2% | Higher Growth | HCM |
| Operating Margin (TTM) Profitability | N/A | -6.3% | Higher Margin | HCM |
| Net Profit Margin Profitability | N/A | 3.3% | Higher Margin | HCM |
| Return on Equity (ROE) Capital Efficiency | N/A | 1.5% | Higher ROE | HCM |
| 52-Week Range Position Momentum | 0% ($2โ$9) | 53% ($10โ$16) | Stronger Trend | HCM |
| Beta / 30D Volatility Risk Regime | 2.19ฮฒ ยท 100% Vol | 0.64ฮฒ ยท 45% Vol | Lower Realized Risk | HCM |
| Unified Institutional Score Composite Signal | 38.2 / 100 (SELL) | 38.1 / 100 (SELL) | Higher Composite | Tie |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BMM vs HCM Buy Guide
BMM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
HCM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
73rd %ile
IV Regime
Elevated (60thโ80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BMM nor HCM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.